+44 1300 500008Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
59 | 57 | 32 | 59 | 77 | 13 | 11 | 20 | 37 | 22 | 37 | 55 | 22 | 12 |
Research, Review articles and Editorials |
1 | 0 | 5 | 42 | 32 | 12 | 10 | 14 | 27 | 21 | 33 | 44 | 21 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
48 | 57 | 27 | 17 | 45 | 1 | 1 | 6 | 10 | 1 | 4 | 11 | 1 | 2 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 51 | 125 | 100 | 191 | 0 | 125 | 177 |
Citations received as per Google Scholar, other indexing platforms and portals |
98 | 160 | 172 | 269 | 223 | 172 | 219 | 195 | 170 | 116 | 60 | 36 | 26 | 58 |
| Journal total citations count | 2004 |
| Journal impact factor | 5.32 |
| Journal 5 years impact factor | 5.62 |
| Journal cite score | 5.3 |
| Journal h-index | 22 |
| Journal h-index since 2019 | 17 |
Important citations (1101)
Novel ?-coronavirus (sars-cov-2): current and future aspects of pharmacological treatments. |
|
The spectrum of antibiotic prescribing during covid-19 pandemic: a systematic literature review |
|
Therapeutic options for coronavirus disease 2019 (covid-19) - modulation of type i interferon response as a promising strategy? |
|
what the dental practitioner needs to know about pharmaco-therapeutic modalities of covid-19 treatment: a review. |
|
therapeutic options for covid-19: a quick review. |
|
Azithromycin, a questionable treatment for covid-19 |
|
Use of hydroxychloroquine and chloroquine in patients with covid-19: a meta-analysis of randomized clinical trials. |
|
insights of severe acute respiratory syndrome coronavirus (sars-cov-2) pandemic: a current review |
|
Inhibitory capacity of chloroquine against sars-cov-2 by effective binding with angiotensin converting enzyme-2 receptor: an insight from molecular docking and md-simulation studies |
|
Study of the structural, chemical descriptors and optoelectronic properties of the drugs hydroxychloroquine and azithromycin |
|
Repurposing drugs for treatment of sars-cov-2 infection: computational design insights into mechanisms of action. |
|
Antimalarial and cytotoxic drugs on covid-19 and the cardiovascular burden: literature review and lessons to be learned |
|
erythromycin estolate inhibits zika virus infection by blocking viral entry as a viral inactivator |
|
recent progress in the repurposing of drugs/molecules for the management of covid-19 |
|
Covid-19 and therapeutic drugs repurposing in hand: the need for collaborative efforts |
|
in silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against sars-cov-2 infection. |
|
review of pharmacologic and immunologic agents in the management of covid-19. |
|
Potential anti-covid-19 therapeutics that block the early stage of the viral life cycle: structures, mechanisms, and clinical trials |
|
effective drugs used to combat sars-cov-2 infection and the current status of vaccines. |
|
Sars-cov-2: pathogenesis, and advancements in diagnostics and treatment. |
|